Position in AKTS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,789,000
New position
Shares Held
100,000
first reported quarter
Ownership
0.180%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Laurion Capital Management LP holds $278,142,488 across 19 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
1,352,234 | $100,714,388 | |
| 2 | MLYS |
Mineralys Therapeutics, Inc.
|
2,506,152 | $67,615,980 | |
| 3 | NUVB |
Nuvation Bio Inc.
|
7,820,013 | $44,417,673 | |
| 4 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
2,002,701 | $15,260,581 | |
| 5 | PYXS |
Pyxis Oncology, Inc.
|
4,900,888 | $14,751,672 | |
| 6 | IMUX |
Immunic, Inc.
|
610,326 | $9,380,710 | |
| 7 | AARD |
Aardvark Therapeutics, Inc.
|
1,034,459 | $5,958,483 | |
| 8 | AUTL |
Autolus Therapeutics plc
|
3,316,626 | $5,306,601 |
All Filings in AKTS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,789,000 | 100,000 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||